<insert video>


Faculty

Moderators
Patricia  A. Takach, MD, FAAAAI
University of Pennsylvania

Christopher Calabria, MD FAAAAI
Dilley Allergy and Asthma Specialists

Safe Subcutaneous Immunotherapy Dosing Adjustments Following Prolonged Interruptions In Therapy Due To Covid-19 Pandemic.
Lois Kang

Effect of house dust mite sublingual immunotherapy in patients with Atopic Dermatitis: a randomized, double-blind, placebo-controlled clinical trial
Sarah  S. Langer, MD
Universidade de Sao Paulo USP

Role of Acid-sensing Ion Channel 1 in sensing acidification and triggering inflammation in Nasal Polyps with Asthma
Hai Lin, MD PhD
Shanghai Sixth People's Hospital

Temporal Trends of Skin Prick Tests
Pasquale Mule
McGill University

Non-specific Lipid Transfer Protein (Can s 3) Is a Relevant Cannabis Allergen in North America
Henry  P. Morelli
Thomas Jefferson University

Intranasal Ketorolac, Diagnosis and Desensitization for Aspirin Exacerbated Respiratory Disease (AERD)
Amie Nguyen, MD
Kaiser Permanente Los Angeles Medical Center

EDS-FLU (Exhalation Delivery System With Fluticasone) is Associated With Improved Sleep in Patients With Nasal Polyposis
Anuja Kapil, MD

Systemic Reaction Rates in Subcutaneous Immunotherapy Patients Monitored Outside of Clinic
Alyssa Osheim
Greater Austin Allergy, Asthma, and Immunology

The 12-SQ HDM SLIT-Tablet Shows Similar Safety and Efficacy Across Geographies, Ethnic and Age Groups
David  I. Bernstein, MD FAAAAI
Bernstein Allergy Group, Inc